BCA
Bay Colony Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,989
| Closed | -$215K | – | 440 |
|
|
2024
Q2 | $215K | Sell |
3,989
-186
| -4% | -$10K | 0.04% | 374 |
|
|
2024
Q1 | $285K | Sell |
4,175
-758
| -15% | -$51.7K | 0.05% | 298 |
|
|
2023
Q4 | $309K | Sell |
4,933
-1,950
| -28% | -$122K | 0.06% | 269 |
|
|
2023
Q3 | $312K | Sell |
6,883
-125
| -2% | -$5.67K | 0.08% | 231 |
|
|
2023
Q2 | $393K | Sell |
7,008
-62
| -0.9% | -$3.48K | 0.1% | 191 |
|
|
2023
Q1 | $312K | Sell |
7,070
-100
| -1% | -$4.42K | 0.08% | 224 |
|
|
2022
Q4 | $291K | Sell |
7,170
-200
| -3% | -$8.13K | 0.08% | 251 |
|
|
2022
Q3 | $482K | Hold |
7,370
| – | – | 0.14% | 153 |
|
|
2022
Q2 | $553K | Buy |
7,370
+1,600
| +28% | +$120K | 0.14% | 157 |
|
|
2022
Q1 | $362K | Buy |
5,770
+498
| +9% | +$31.2K | 0.09% | 231 |
|
|
2021
Q4 | $400K | Buy |
5,272
+1,301
| +33% | +$98.7K | 0.11% | 217 |
|
|
2021
Q3 | $444K | Sell |
3,971
-28
| -0.7% | -$3.13K | 0.15% | 186 |
|
|
2021
Q2 | $647K | Hold |
3,999
| – | – | 0.22% | 133 |
|
|
2021
Q1 | $487K | Buy |
3,999
+1,429
| +56% | +$174K | 0.19% | 152 |
|
|
2020
Q4 | $393K | Sell |
2,570
-1,225
| -32% | -$187K | 0.21% | 150 |
|
|
2020
Q3 | $317K | Buy |
3,795
+745
| +24% | +$62.2K | 0.2% | 159 |
|
|
2020
Q2 | $224K | Buy |
+3,050
| New | +$224K | 0.16% | 172 |
|
|
2020
Q1 | – | Sell |
-3,950
| Closed | -$231K | – | 186 |
|
|
2019
Q4 | $231K | Sell |
3,950
-1,000
| -20% | -$58.5K | 0.15% | 229 |
|
|
2019
Q3 | $203K | Hold |
4,950
| – | – | 0.14% | 237 |
|
|
2019
Q2 | $233K | Sell |
4,950
-950
| -16% | -$44.7K | 0.15% | 184 |
|
|
2019
Q1 | $206K | Buy |
+5,900
| New | +$206K | 0.14% | 192 |
|